{"product_id":"veterinary-pharmacology-and-therapeutics-isbn-9781118855829","title":"Veterinary Pharmacology and Therapeutics","description":"\u003cp\u003e\u003ci\u003eVeterinary Pharmacology and Therapeutics, Tenth Edition \u003c\/i\u003eis a fully updated and revised version of the gold-standard reference on the use of drug therapy in all major veterinary species.  \u003c\/p\u003e \u003cul\u003e \u003cli\u003eProvides current, detailed information on using drug therapies in all major domestic animal species\u003c\/li\u003e \u003cli\u003eOrganized logically by drug class and treatment indication, with exhaustive information on the rational use of drugs in veterinary medicine\u003c\/li\u003e \u003cli\u003eIncludes extensive tables of pharmacokinetic data, products available, and dosage regimens\u003c\/li\u003e \u003cli\u003eAdds new chapters on pharmaceutics, ophthalmic pharmacology, food animal pharmacology, and aquatic animal pharmacology\u003c\/li\u003e \u003cli\u003eIncludes access to a companion website with the figures from the book in PowerPoint\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003eContributors xiii\u003c\/p\u003e \u003cp\u003ePreface xix\u003c\/p\u003e \u003cp\u003eAbout the Companion Website xxi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1 Principles of Pharmacology \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Veterinary Pharmacology: An Introduction to the Discipline 3\u003cbr\u003e\u003ci\u003eJim E. Riviere and Mark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Absorption, Distribution, Metabolism, and Elimination 8\u003cbr\u003e\u003ci\u003eJim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Pharmacokinetics 41\u003cbr\u003e\u003ci\u003eJim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Mechanism of Drug Action and Pharmacokinetics\/ Pharmacodynamics Integration in Dosage Regimen Optimization for Veterinary Medicine 65\u003cbr\u003e\u003ci\u003ePierre-Louis Toutain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Principles of Pharmaceutics and Veterinary Dosage Forms 87\u003cbr\u003e\u003ci\u003eRaafat M. Fahmy and Marilyn N. Martinez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2 Drugs Acting on the Autonomic Nervous System \u003c\/b\u003e\u003cb\u003e111\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6 Introduction to the Autonomic Nervous System and Autonomic Pharmacology 113\u003cbr\u003e\u003ci\u003eJoshua A. Rowe, Rose M. McMurphy, Barbara J. Lutjemeier, and Michael J. Kenney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Adrenergic Receptor Agonists and Antagonists 131\u003cbr\u003e\u003ci\u003eRose M. McMurphy, Elizabeth G. Davis, Amy J. Rankin, Daniel A. Frese, Barbara J. Lutjemeier, and ;Michael J. Kenney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Cholinergic Pharmacology: Autonomic Drugs 151\u003cbr\u003e\u003ci\u003eRose M. McMurphy, Elizabeth G. Davis, Amy J. Rankin, Marjory A. Artzer, Barbara J. Lutjemeier, and Michael J. Kenney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3 Anesthetics and Analgesics, and Drugs Acting on the Central Nervous System \u003c\/b\u003e\u003cb\u003e165\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9 Introduction to Drugs Acting on the Central Nervous System and Principles of Anesthesiology 167\u003cbr\u003e\u003ci\u003ePeter J. Pascoe and Eugene P. Steffey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Neuromuscular Blocking Agents 194\u003cbr\u003e\u003ci\u003eDiane E .Mason and Christopher L. Norkus\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Inhalation Anesthetics 216\u003cbr\u003e\u003ci\u003eRobert J. Brosnan and Eugene P. Steffey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Injectable Anesthetic Agents 247\u003cbr\u003e\u003ci\u003eLysa P. Posner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Opioid Analgesic Drugs 281\u003cbr\u003e\u003ci\u003eButch KuKanich and Mark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Sedatives and Tranquilizers 324\u003cbr\u003e\u003ci\u003eLysa P. Posner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Local Anesthetics 369\u003cbr\u003e\u003ci\u003eThomas W. Vickroy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Euthanizing Agents 387\u003cbr\u003e\u003ci\u003eAnna Hampton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Anticonvulsant Drugs 395\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Drugs Affecting Animal Behavior 416\u003cbr\u003e\u003ci\u003eMargaret E. Gruen, Barbara L. Sherman, and Mark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 4 Autacoids and Antiinflammatory Drugs \u003c\/b\u003e\u003cb\u003e449\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e19 Histamine, Serotonin, and their Antagonists 451\u003cbr\u003e\u003ci\u003eWolfgang Ba\u003c\/i\u003e\u003ci\u003eumer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Analgesic, Antiinflammatory, Antipyretic Drugs 467\u003cbr\u003e\u003ci\u003ePeter Lees\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 5 Drugs Acting on the Cardiovascular System \u003c\/b\u003e\u003cb\u003e501\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e21 Digitalis, Positive Inotropes, and Vasodilators 503\u003cbr\u003e\u003ci\u003eClarke E. Atkins and Marisa K. Ames\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Antiarrhythmic Agents 537\u003cbr\u003e\u003ci\u003eKathryn M. Meurs and Jim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 6 Drugs Affecting Renal Function and Fluid–Electrolyte Balance \u003c\/b\u003e\u003cb\u003e553\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e23 Principles of Acid–Base Balance: Fluid and Electrolyte Therapy, Blood Substitutes 555\u003cbr\u003e\u003ci\u003eMaya M. Scott-Garrard, Melisa Rosenthal, and Deborah T. Kochevar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Diuretics and Renal Pharmacology 593\u003cbr\u003e\u003ci\u003eButch Kukanich and Deborah T. Kochevar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 7 Drugs Acting on Blood and Blood Elements \u003c\/b\u003e\u003cb\u003e623\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e25 Anticoagulant, Antiplatelet, and Hemostatic Drugs 625\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8 Endocrine Pharmacology \u003c\/b\u003e\u003cb\u003e647\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e26 Hypothalamic and Pituitary Hormones 649\u003cbr\u003e\u003ci\u003eSrujana Rayalam, Margarethe Hoenig, and Duncan C. Ferguson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Hormones Affecting Reproduction 674\u003cbr\u003e\u003ci\u003eWolfgang Ba\u003c\/i\u003e\u003ci\u003eumer, C. Scott Bailey, and John Gadsby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Thyroid Hormone and Antithyroid Drugs 691\u003cbr\u003e\u003ci\u003eDuncan C. Ferguson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Glucocorticoids, Mineralocorticoids, and Adrenolytic Drugs 729\u003cbr\u003e\u003ci\u003eDuncan C. Ferguson and Margarethe Hoenig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Drugs Influencing Glucose Metabolism 763\u003cbr\u003e\u003ci\u003eMargarethe Hoenig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 9 Chemotherapy of Microbial Diseases \u003c\/b\u003e\u003cb\u003e779\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31 Antiseptics and Disinfectants 781\u003cbr\u003e\u003ci\u003eMegan E. Jacob\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Sulfonamides and Potentiated Sulfonamides 796\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 𝛃-Lactam Antibiotics: Penicillins, Cephalosporins, and Related Drugs 826\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Tetracycline Antibiotics 858\u003cbr\u003e\u003ci\u003eMark G. Papich and Jim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Aminoglycoside Antibiotics 877\u003cbr\u003e\u003ci\u003eMark G. Papich and Jim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Chloramphenicol and Derivatives, Macrolides, Lincosamides, and Miscellaneous Antimicrobials 903\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Fluoroquinolone Antimicrobial Drugs 953\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Antifungal and Antiviral Drugs 988\u003cbr\u003e\u003ci\u003eJennifer L. Davis and Lara Maxwell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 10 Chemotherapy of Parasitic Diseases \u003c\/b\u003e\u003cb\u003e1033\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e39 Antinematodal Drugs 1035\u003cbr\u003e\u003ci\u003eCarlos E. Lanusse, Juan M. Sallovitz, Sergio F. Sanchez Bruni, and Luis I. Alvarez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Anticestodal and Antitrematodal Drugs 1081\u003cbr\u003e\u003ci\u003eCarlos E. Lanusse, Luis I. Alvarez, and Guillermo L. Virkel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Macrocyclic Lactones: Endectocide Compounds 1102\u003cbr\u003e\u003ci\u003eCarlos E. Lanusse, Fernanda A. Imperiale, and Adrian L. Lifschitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Antiprotozoan Drugs 1128\u003cbr\u003e\u003ci\u003eJennifer L. Davis and Jody L. Gookin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Ectoparasiticides 1166\u003cbr\u003e\u003ci\u003eRonald E. Baynes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 11 Specialty Areas of Pharmacology \u003c\/b\u003e\u003cb\u003e1189\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e44 Chemotherapy of Neoplastic Diseases 1191\u003cbr\u003e\u003ci\u003eLuke A.Wittenburg and Daniel L. Gustafson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Immunosuppressive Drugs 1226\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Drugs for Treating Gastrointestinal Diseases 1245\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Dermatopharmacology: Drugs Acting Locally on the Skin 1278\u003cbr\u003e\u003ci\u003eJim E. Riviere and Rosanna Marsella\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 Drugs that Affect the Respiratory System 1302\u003cbr\u003e\u003ci\u003eMark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Ophthalmic Pharmacology 1321\u003cbr\u003e\u003ci\u003eAlison Clode\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Pharmacogenomics 1332\u003cbr\u003e\u003ci\u003eKatrina L. Mealey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Considerations for Treating Minor Food-Producing Animals with Veterinary Pharmaceuticals 1345\u003cbr\u003e\u003ci\u003eLisa A. Tell, Margaret Oeller, Tara Marmulak, and Ronette Gehring\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 Unique Considerations Pertaining to the Use of Drugs in Food Animals 1358\u003cbr\u003e\u003ci\u003eMichael D. Apley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e53 Pharmacology in Aquatic Animals 1373\u003cbr\u003e\u003ci\u003eRon A. Miller\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e54 Zoological Pharmacology 1395\u003cbr\u003e\u003ci\u003eRobert P. Hunter\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 12 Regulatory and Other Considerations \u003c\/b\u003e\u003cb\u003e1405\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e55 The Regulation of Animal Drugs 1407\u003cbr\u003e\u003ci\u003eSteven D. Vaughn and Marilyn N. Martinez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Veterinary Pharmacy 1427\u003cbr\u003e\u003ci\u003eGigi Davidson and Mark G. Papich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 Medication Control Programs in Performance Animals 1439\u003cbr\u003e\u003ci\u003eCynthia A. Cole\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Pharmacovigilance 1448\u003cbr\u003e\u003ci\u003eJohn D. Baker, Susan J. Bright-Ponte, and Lee Anne M. Palmer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 Dosage Forms and Veterinary Feed Directives 1459\u003cbr\u003e\u003ci\u003eGeof Smith and Jim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Evidence-Based Pharmacotherapy 1465\u003cbr\u003e\u003ci\u003eRonette Gehring\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Chemical Residues in Tissues of Food Animals 1469\u003cbr\u003e\u003ci\u003eJim E. Riviere\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 1481\u003c\/p\u003e   \u003cp\u003e \u003cstrong\u003eThe editors\u003cbr\u003e Jim E. Riviere, DVM, PhD, DSc (hon), ATS,\u003c\/strong\u003e is The MacDonald Chair in Veterinary Medicine, University Distinguished Professor, Kansas Bioscience Eminent Scholar, and Director, Institute of Computational Comparative Medicine at Kansas State University in Manhattan, Kansas, USA. He is also a Distinguished Professor Emeritus at North Carolina State University in Raleigh, North Carolina, USA.  \t \u003c\/p\u003e\u003cp\u003e \u003cstrong\u003eMark G. Papich, DVM, MS, Diplomate ACVCP, \u003c\/strong\u003ehas the Burroughs Wellcome Professorship in Veterinary Pharmacology and is a Professor of Clinical Pharmacology, Department of Molecular Biomedical Sciences, College of Veterinary Medicine at North Carolina State University in Raleigh, North Carolina, USA.      \u003c\/p\u003e\u003cp\u003e \u003cem\u003eVeterinary Pharmacology and Therapeutics, Tenth Edition\u003c\/em\u003e is a fully updated and revised version of the gold-standard reference on the use of drug therapy in all major veterinary species. Organized by drug class as well as therapeutic use, the book provides exhaustive information on pharmacology in veterinary medicine, focusing on drugs currently used in practice. Written by an international group of top pharmacologists and clinical experts, the new edition adds chapters on pharmaceutics, ophthalmic pharmacology, food animal pharmacology, and aquatic animal pharmacology.   \u003c\/p\u003e\u003cp\u003e Offering detailed, authoritative information on pharmacological applications in veterinary medicine, the new edition provides current guidance on drug therapies based on the latest published evidence. A companion website offers the figures from the book in PowerPoint. \u003cem\u003eVeterinary Pharmacology and Therapeutics, Tenth Edition\u003c\/em\u003e is an indispensable resource for veterinarians, veterinary students, veterinary interns and residents, graduate students in comparative biomedical sciences, laboratory animal specialists, drug regulators, and animal science researchers.    \u003c\/p\u003e\u003cp\u003e \u003cstrong\u003eKey features\u003c\/strong\u003e   \u003c\/p\u003e\u003cul\u003e \u003cli\u003eProvides current, detailed information on using drug therapies in all major domestic animal species\u003c\/li\u003e \u003cli\u003eOrganized logically by drug class and treatment indication, with exhaustive information on the rational use of drugs in veterinary medicine\u003c\/li\u003e \u003cli\u003eIncludes extensive tables of pharmacokinetic data, products available, and dosage regimens\u003c\/li\u003e \u003cli\u003eAdds new chapters on pharmaceutics, ophthalmic pharmacology, food animal pharmacology, and aquatic animal pharmacology\u003c\/li\u003e \u003cli\u003eIncludes access to a companion website with the figures from the book in PowerPoint\u003c\/li\u003e \u003c\/ul\u003e \u003cbr\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990451667173,"sku":"NP9781118855829","price":245.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118855829.jpg?v=1761787887","url":"https:\/\/k12savings.com\/es\/products\/veterinary-pharmacology-and-therapeutics-isbn-9781118855829","provider":"K12savings","version":"1.0","type":"link"}